3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Motor Activity
3
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Obesity
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
fludarabine phosphate
27
Peripheral Blood Stem Cell Transplantation
25
Cyclophosphamide
24
Busulfan
17
Tacrolimus
16
Whole-Body Irradiation
15
Mycophenolic Acid
14
Methotrexate
12
Cyclosporine
12
Antilymphocyte Serum
10
Melphalan
7
Filgrastim
7
Etoposide
7
fludarabine
6
Radiotherapy
5
Decitabine
5
Carboplatin
5
ruxolitinib
4
Topotecan
4
Methylprednisolone
4
Flow Cytometry
4
Cytarabine
4
Thiotepa
3
Imatinib Mesylate
3
Cytogenetic Analysis
3
Alemtuzumab
3
veliparib
2
merphos
2
liposomal amphotericin B
2
aldesleukin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycythemia Vera
×
Resistance Training
×
Other hematologic neoplasm
×
Clear all
NCT07518940
2026-04-09
ENERGIA
University of Turin, Italy
Phase NA
Not yet recruiting
25 enrolled